Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 24/06 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 24/06 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 626.65Cr 550.39Cr 511.85Cr 469.69Cr 882.51Cr 60TCr 896.11Cr 6.08TCr 2.37TCr 30TCr 2.35TCr 2.3TCr 1,02600Cr | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 609.03Cr 534.91Cr 497.46Cr 456.48Cr 857.69Cr 59TCr 870.92Cr 5.91TCr 2.31TCr 29TCr 2.29TCr 2.24TCr 1LCr | EV / Sales 2024 |
-
| EV / Sales 2025 | 23,18,10,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +2.61% | ||
| 6 months | +60.27% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/06/26 | Issuer sale | Director | -3,92,474 | 0.2537% | ||
| 24/06/26 | Issuer sale | Director | -2,48,570 | 0.1606% | ||
| 24/06/26 | Issuer sale | Director | -2,32,000 | 0.1499% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +162.82% | +467.23% | 626.65Cr | |
| +1.07% | -3.49% | -3.35% | +10.44% | 4.69TCr | |
| +0.25% | +1.65% | +399.22% | +634.87% | 4.02TCr | |
| -0.27% | +4.45% | +11.81% | +65.64% | 3.62TCr | |
| +0.35% | +0.87% | +4.46% | -10.16% | 3.47TCr | |
| +3.14% | +1.02% | +4.76% | +40.92% | 2.79TCr | |
| -0.73% | +11.84% | +34.39% | +134.36% | 1.68TCr | |
| +0.47% | -2.74% | - | - | 1.67TCr | |
| +0.42% | -5.52% | -3.43% | +9.03% | 1.31TCr | |
| -2.68% | -2.49% | -11.36% | -33.61% | 1.27TCr | |
| Average | +0.28% | +0.94% | +66.59% | +146.53% | 2.52TCr | |
| Weighted average by Cap. | +0.49% | +0.94% | +76.78% | +145.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.17 12.25 11.24 21.12 1.44T 21.45 145.49 56.84 710.17 56.31 55.1 2.46T |
| Net income | -24Cr -21Cr -19Cr -18Cr -33Cr -2.27TCr -34Cr -228.67Cr -89Cr -1.12TCr -89Cr -87Cr -3.86TCr | -20Cr -17Cr -16Cr -15Cr -28Cr -1.9TCr -28Cr -191.59Cr -75Cr -935.21Cr -74Cr -73Cr -3.23TCr |
| Net Debt | -36Cr -32Cr -30Cr -27Cr -51Cr -3.51TCr -52Cr -353.39Cr -138.07Cr -1.73TCr -136.78Cr -133.83Cr -5.96TCr | -18Cr -15Cr -14Cr -13Cr -25Cr -1.7TCr -25Cr -170.9Cr -67Cr -834.21Cr -66Cr -65Cr -2.88TCr |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
